Published in J Urol on August 01, 1995
Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr Nephrol (2009) 1.45
Congenital ureteropelvic junction obstruction: human disease and animal models. Int J Exp Pathol (2010) 0.99
Chronic partial ureteral obstruction and the developing kidney. Pediatr Radiol (2007) 0.83
Renal pyramid echogenicity in ureteropelvic junction obstruction: correlation between altered echogenicity and differential renal function. Pediatr Radiol (2008) 0.78
Evaluation of Renal Histopathological Changes, as a Predictor of Recoverability of Renal Function Following Pyeloplasty for Ureteropelvic Junction Obstruction. Nephrourol Mon (2015) 0.75
Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med (1991) 6.16
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med (1990) 5.65
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med (2001) 3.44
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation (1996) 3.14
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation (1986) 2.69
Ultrasequencing of the meiofaunal biosphere: practice, pitfalls and promises. Mol Ecol (2010) 2.64
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation (2000) 2.49
Complications of circumcision. Urol Clin North Am (1983) 2.39
Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation (1998) 2.35
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg (1999) 2.26
N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation (1994) 2.05
Congenital pulmonary alveolar proteinosis: failure of treatment with extracorporeal life support. J Pediatr (1992) 2.05
Comparison of captopril and enalapril in patients with severe chronic heart failure. N Engl J Med (1986) 1.79
Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med (1987) 1.71
Preoperative laparoscopic localization of the nonpalpable testis: a critical analysis of a 10-year experience. J Urol (1994) 1.71
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation (1994) 1.67
Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation (1985) 1.65
Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol (1995) 1.63
Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol (1989) 1.61
Prostatic utricle cysts (müllerian duct cysts). J Urol (1978) 1.60
Decreased serotonergic receptor binding in rhombic lip-derived regions of the medulla oblongata in the sudden infant death syndrome. J Neuropathol Exp Neurol (2000) 1.56
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. Eur Heart J (2000) 1.55
Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol (1989) 1.52
Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation (1995) 1.49
Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. N Engl J Med (1984) 1.49
Age- and species-specific duration of infection in asymptomatic malaria infections in Papua New Guinea. Parasitology (2000) 1.46
Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J (2001) 1.46
The core content of a generalist curriculum for general internal medicine, family practice, and pediatrics. J Gen Intern Med (1994) 1.46
A prospective multicenter clinical trial to evaluate the safety and effectiveness of the implantable miniature telescope. Am J Ophthalmol (2004) 1.44
Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg (1994) 1.40
Accessory and ectopic scrota. Urology (1977) 1.40
Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure. Circulation (1990) 1.39
Deleterious effects of hydralazine in patients with pulmonary hypertension. N Engl J Med (1982) 1.38
Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. Circulation (1996) 1.38
Systemic candidiasis in infants: a case presentation and literature review. Am J Dis Child (1977) 1.35
Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Circulation (1979) 1.35
Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Ann Intern Med (1987) 1.31
Molecular and phenotypic variability in the congenital alveolar proteinosis syndrome associated with inherited surfactant protein B deficiency. J Pediatr (1994) 1.30
Use of power modulations in phacoemulsification. Choo-choo chop and flip phacoemulsification. J Cataract Refract Surg (2001) 1.24
Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol (1994) 1.24
Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure. Circulation (1985) 1.22
End of the oldest controversy in medicine. Are we ready to conclude the debate on digitalis? N Engl J Med (1997) 1.21
Fatal infections with echovirus types 6 and 11 in early infancy. Am J Dis Child (1973) 1.20
Indications for left ventricular aneurysmectomy. Circulation (1983) 1.20
Embryogenesis of chordee. J Urol (1975) 1.16
Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Coll Cardiol (1990) 1.15
Carcinoma of the male urethra. J Urol (1967) 1.15
Hemodynamic and clinical effects of combined verapamil and propranolol therapy in angina pectoris. Am J Cardiol (1982) 1.14
Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation (1987) 1.11
Megalourethra. J Urol (1986) 1.11
Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failure. Am Heart J (1987) 1.10
Do vasodilators prolong life in heart failure? N Engl J Med (1987) 1.09
Etiology, diagnosis, and management of urethral strictures in children. Urol Clin North Am (1990) 1.09
How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind men. J Am Coll Cardiol (1987) 1.08
Neonatal circumcision. Urol Clin North Am (1995) 1.08
Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management. Postgrad Med J (1986) 1.07
Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation (2000) 1.06
The cystic renal lesion in tuberous sclerosis. J Pediatr (1980) 1.06
Association of human DEAD box protein DDX1 with a cleavage stimulation factor involved in 3'-end processing of pre-MRNA. Mol Biol Cell (2001) 1.05
Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism. J Am Coll Cardiol (1983) 1.04
Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? J Am Coll Cardiol (1996) 1.04
Physiologic and pharmacologic determinants of vasodilator response: a conceptual framework for rational drug therapy for chronic heart failure. Prog Cardiovasc Dis (1982) 1.04
Pulmonary toxicity due to bleomycin. Report of a case. Arch Pathol (1973) 1.03
Second report of a translocation involving 19q13.4 in a mesenchymal hamartoma of the liver. Cancer Genet Cytogenet (1992) 1.03
Verapamil therapy for stable and unstable angina pectoris: calcium channel antagonists in perspective. Am J Cardiol (1982) 1.03
Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study. J Am Coll Cardiol (1993) 1.02
Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure. N Engl J Med (1982) 1.02
Prepubertal yolk sac testicular tumors--report of the testicular tumor registry. J Urol (1988) 1.02
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group. J Card Fail (1997) 1.02
An analysis of the usefulness of specific stages in the pathologic investigation of sudden infant death. Am J Forensic Med Pathol (2000) 1.02
The search for the ideal positive inotropic agent. N Engl J Med (1993) 1.02
Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. Circulation (1983) 1.02
Circumcision--an overview. Curr Probl Pediatr (1977) 1.02
Location and fate of the nonpalpable testis in children. J Urol (1983) 1.01
Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition. Ann Intern Med (1984) 1.01
The role of vasodilator therapy in the treatment of severe chronic heart failure. Drugs (1986) 1.01
Acute scrotal swelling in children. J Urol (1970) 1.01
Progressive cough associated with lymphocytic leukemoid reaction in an infant. J Pediatr (1980) 1.01
Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease. J Am Coll Cardiol (1984) 1.00
Regulation of brain fatty acid-binding protein expression by differential phosphorylation of nuclear factor I in malignant glioma cell lines. J Biol Chem (2000) 1.00
Lesions of Cowper's glands in children. J Urol (1979) 1.00
Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines. J Biol Chem (1998) 1.00
Provocation of hyper- and hypokalemic sudden death during treatment with and withdrawal of converting-enzyme inhibition in severe chronic congestive heart failure. Am J Cardiol (1986) 1.00
Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure. Circulation (1984) 1.00
Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation (1995) 1.00
Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system. Circulation (1986) 0.99
Histopathological findings in a male with late-onset ornithine transcarbamylase deficiency. Pediatr Pathol (1994) 0.99
An alternative approach to myelodysplasia management: aggressive observation and prompt intervention. J Urol (1994) 0.98
Microvascular autotransplantation of the intra-abdominal testis. J Urol (1990) 0.97
A double blind study of sulfa prophylaxis after transurethral resection. Invest Urol (1969) 0.97
Incidence of the bell-clapper deformity in an autopsy series. Urology (1994) 0.97
Klippel-Trenaunay syndrome associated with urinary tract hemangiomas. J Urol (1975) 0.97
Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards. Ann Intern Med (1985) 0.96
Changes in the epidemiologic profile of sudden infant death syndrome as rates decline among California infants: 1990-1995. Pediatrics (1998) 0.96
Pediatric urolithiases: a ten-year review. Pediatrics (1980) 0.96
Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol (1993) 0.96
Activation of neurohumoral systems in postinfarction left ventricular dysfunction. J Am Coll Cardiol (1993) 0.95
Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man. Circulation (1982) 0.94